HK Stock MarketDetailed Quotes

01789 AK MEDICAL

Watchlist
  • 5.160
  • +0.160+3.20%
Trading Apr 23 15:01 CST
5.79BMarket Cap28.83P/E (TTM)

AK MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
3.97%1.09B
22.11%648.69M
38.17%1.05B
18.67%531.21M
-26.46%761.44M
-6.54%447.63M
11.73%1.04B
9.41%478.98M
54.31%926.71M
59.19%437.78M
Operating income
3.97%1.09B
22.11%648.69M
38.17%1.05B
18.67%531.21M
-26.46%761.44M
-6.54%447.63M
11.73%1.04B
9.41%478.98M
54.31%926.71M
59.19%437.78M
Cost of sales
-0.91%-419.38M
-28.26%-247.12M
-58.48%-415.61M
-38.32%-192.68M
18.26%-262.25M
2.35%-139.3M
-13.19%-320.85M
-7.10%-142.66M
-47.88%-283.45M
-58.20%-133.2M
Operating expenses
-0.91%-419.38M
-28.26%-247.12M
-58.48%-415.61M
-38.32%-192.68M
18.26%-262.25M
2.35%-139.3M
-13.19%-320.85M
-7.10%-142.66M
-47.88%-283.45M
-58.20%-133.2M
Gross profit
5.98%674.49M
18.62%401.57M
27.49%636.44M
9.80%338.54M
-30.14%499.19M
-8.32%308.33M
11.08%714.53M
10.42%336.32M
57.32%643.25M
59.63%304.58M
Selling expenses
-21.49%-218.81M
-17.74%-117.41M
3.86%-180.11M
-26.67%-99.71M
-21.57%-187.35M
-25.45%-78.72M
12.11%-154.1M
25.66%-62.75M
-42.69%-175.33M
-68.17%-84.41M
Administrative expenses
-12.79%-133.44M
-37.84%-75.17M
-12.34%-118.31M
-6.86%-54.54M
-26.86%-105.32M
-33.39%-51.04M
9.96%-83.02M
19.55%-38.26M
-24.39%-92.2M
-33.47%-47.56M
Research and development expenses
-23.69%-137.13M
-21.92%-66.33M
1.95%-110.87M
-5.15%-54.4M
-7.71%-113.07M
-17.85%-51.74M
-30.36%-104.97M
-24.95%-43.9M
-76.61%-80.53M
-79.58%-35.13M
Impairment and provision
----
----
---18.36M
----
----
----
---8.85M
----
----
----
-Goodwill impairment
----
----
---18.36M
----
----
----
---8.85M
----
----
----
Special items of operating profit
135.59%26.37M
-78.85%1.05M
87.21%11.19M
138.27%4.96M
12.11%5.98M
120.57%2.08M
-73.77%5.33M
-93.93%943K
311.37%20.33M
3,360.13%15.54M
Operating profit
-3.86%211.48M
6.58%143.71M
121.23%219.98M
4.60%134.84M
-73.05%99.44M
-32.98%128.92M
16.93%368.93M
25.71%192.36M
84.27%315.52M
78.20%153.01M
Financing income
-3.31%19.63M
-2.28%14.28M
122.59%20.31M
442.55%14.61M
18.77%9.12M
-40.35%2.69M
30.61%7.68M
31.44%4.52M
79.68%5.88M
64.67%3.44M
Earning before tax
-3.82%231.12M
5.71%157.99M
121.35%240.29M
13.56%149.45M
-71.17%108.56M
-33.15%131.61M
17.18%376.61M
25.84%196.87M
84.18%321.4M
77.88%156.45M
Tax
-37.99%-49.01M
-8.51%-25.41M
-122.82%-35.52M
-16.35%-23.42M
74.54%-15.94M
40.80%-20.13M
-15.05%-62.6M
-26.42%-34M
-84.04%-54.41M
-62.39%-26.89M
After-tax profit from continuing operations
-11.07%182.1M
5.19%132.57M
121.09%204.77M
13.05%126.03M
-70.50%92.62M
-31.55%111.48M
17.61%314.01M
25.72%162.87M
84.21%266.99M
81.47%129.56M
Earning after tax
-11.07%182.1M
5.19%132.57M
121.09%204.77M
13.05%126.03M
-70.50%92.62M
-31.55%111.48M
17.61%314.01M
25.72%162.87M
84.21%266.99M
81.47%129.56M
Profit attributable to shareholders
-11.07%182.1M
5.19%132.57M
121.09%204.77M
13.05%126.03M
-70.50%92.62M
-31.55%111.48M
17.61%314.01M
25.72%162.87M
84.21%266.99M
81.47%129.56M
Basic earnings per share
-11.11%0.16
9.09%0.12
125.00%0.18
10.00%0.11
-71.43%0.08
-33.33%0.1
7.69%0.28
25.00%0.15
85.71%0.26
71.43%0.12
Diluted earnings per share
-11.11%0.16
9.09%0.12
125.00%0.18
10.00%0.11
-71.43%0.08
-33.33%0.1
12.00%0.28
25.00%0.15
78.57%0.25
71.43%0.12
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
KPMG
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 3.97%1.09B22.11%648.69M38.17%1.05B18.67%531.21M-26.46%761.44M-6.54%447.63M11.73%1.04B9.41%478.98M54.31%926.71M59.19%437.78M
Operating income 3.97%1.09B22.11%648.69M38.17%1.05B18.67%531.21M-26.46%761.44M-6.54%447.63M11.73%1.04B9.41%478.98M54.31%926.71M59.19%437.78M
Cost of sales -0.91%-419.38M-28.26%-247.12M-58.48%-415.61M-38.32%-192.68M18.26%-262.25M2.35%-139.3M-13.19%-320.85M-7.10%-142.66M-47.88%-283.45M-58.20%-133.2M
Operating expenses -0.91%-419.38M-28.26%-247.12M-58.48%-415.61M-38.32%-192.68M18.26%-262.25M2.35%-139.3M-13.19%-320.85M-7.10%-142.66M-47.88%-283.45M-58.20%-133.2M
Gross profit 5.98%674.49M18.62%401.57M27.49%636.44M9.80%338.54M-30.14%499.19M-8.32%308.33M11.08%714.53M10.42%336.32M57.32%643.25M59.63%304.58M
Selling expenses -21.49%-218.81M-17.74%-117.41M3.86%-180.11M-26.67%-99.71M-21.57%-187.35M-25.45%-78.72M12.11%-154.1M25.66%-62.75M-42.69%-175.33M-68.17%-84.41M
Administrative expenses -12.79%-133.44M-37.84%-75.17M-12.34%-118.31M-6.86%-54.54M-26.86%-105.32M-33.39%-51.04M9.96%-83.02M19.55%-38.26M-24.39%-92.2M-33.47%-47.56M
Research and development expenses -23.69%-137.13M-21.92%-66.33M1.95%-110.87M-5.15%-54.4M-7.71%-113.07M-17.85%-51.74M-30.36%-104.97M-24.95%-43.9M-76.61%-80.53M-79.58%-35.13M
Impairment and provision -----------18.36M---------------8.85M------------
-Goodwill impairment -----------18.36M---------------8.85M------------
Special items of operating profit 135.59%26.37M-78.85%1.05M87.21%11.19M138.27%4.96M12.11%5.98M120.57%2.08M-73.77%5.33M-93.93%943K311.37%20.33M3,360.13%15.54M
Operating profit -3.86%211.48M6.58%143.71M121.23%219.98M4.60%134.84M-73.05%99.44M-32.98%128.92M16.93%368.93M25.71%192.36M84.27%315.52M78.20%153.01M
Financing income -3.31%19.63M-2.28%14.28M122.59%20.31M442.55%14.61M18.77%9.12M-40.35%2.69M30.61%7.68M31.44%4.52M79.68%5.88M64.67%3.44M
Earning before tax -3.82%231.12M5.71%157.99M121.35%240.29M13.56%149.45M-71.17%108.56M-33.15%131.61M17.18%376.61M25.84%196.87M84.18%321.4M77.88%156.45M
Tax -37.99%-49.01M-8.51%-25.41M-122.82%-35.52M-16.35%-23.42M74.54%-15.94M40.80%-20.13M-15.05%-62.6M-26.42%-34M-84.04%-54.41M-62.39%-26.89M
After-tax profit from continuing operations -11.07%182.1M5.19%132.57M121.09%204.77M13.05%126.03M-70.50%92.62M-31.55%111.48M17.61%314.01M25.72%162.87M84.21%266.99M81.47%129.56M
Earning after tax -11.07%182.1M5.19%132.57M121.09%204.77M13.05%126.03M-70.50%92.62M-31.55%111.48M17.61%314.01M25.72%162.87M84.21%266.99M81.47%129.56M
Profit attributable to shareholders -11.07%182.1M5.19%132.57M121.09%204.77M13.05%126.03M-70.50%92.62M-31.55%111.48M17.61%314.01M25.72%162.87M84.21%266.99M81.47%129.56M
Basic earnings per share -11.11%0.169.09%0.12125.00%0.1810.00%0.11-71.43%0.08-33.33%0.17.69%0.2825.00%0.1585.71%0.2671.43%0.12
Diluted earnings per share -11.11%0.169.09%0.12125.00%0.1810.00%0.11-71.43%0.08-33.33%0.112.00%0.2825.00%0.1578.57%0.2571.43%0.12
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor KPMG--KPMG--KPMG--KPMG--KPMG--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg